Peter L. Collins spends much of his time researching Virology, Virus, Molecular biology, Paramyxoviridae and Immunology. Peter L. Collins is involved in the study of Virology that focuses on Respiratory syncytial virus in particular. His study of Viral replication is a part of Virus.
His Molecular biology research is multidisciplinary, relying on both Amino acid and Peptide sequence, Transcription, Gene. His studies deal with areas such as Attenuated vaccine and Interferon as well as Paramyxoviridae. In his study, which falls under the umbrella issue of Immunology, Adenosine, Secretion, Cystic fibrosis transmembrane conductance regulator and Hormone transport is strongly linked to Cell biology.
Peter L. Collins mostly deals with Virology, Virus, Viral replication, Molecular biology and Gene. Peter L. Collins specializes in Virology, namely Paramyxoviridae. The various areas that Peter L. Collins examines in his Paramyxoviridae study include Sendai virus and Vaccinia.
He combines subjects such as Attenuated vaccine, Recombinant virus, Immune system and Microbiology with his study of Virus. His Viral replication research includes themes of Interferon, Syncytium, Glycoprotein, Reverse genetics and Virulence. While the research belongs to areas of Molecular biology, he spends his time largely on the problem of Mutant, intersecting his research to questions surrounding Mutation.
His primary areas of study are Virology, Virus, Immunogenicity, Viral replication and Antibody. Peter L. Collins has researched Virology in several fields, including Attenuated vaccine and Recombinant DNA. He is studying Respiratory syncytial virus, which is a component of Virus.
His work deals with themes such as Vero cell, Respiratory Syncytial Virus Vaccines, Codon usage bias, Fusion protein and Open reading frame, which intersect with Immunogenicity. Peter L. Collins works mostly in the field of Viral replication, limiting it down to topics relating to Virulence and, in certain cases, Microbiology and Cleavage. His Antigen research incorporates themes from Mutant, Viral matrix protein, Messenger RNA, Transcription and Nasal administration.
His main research concerns Virology, Virus, Immunogenicity, Viral replication and Attenuated vaccine. His Virology study incorporates themes from Taxonomy, Cytokine and A549 cell. His biological study spans a wide range of topics, including RNA virus, Gene and Microbiology.
His study in Immunogenicity is interdisciplinary in nature, drawing from both Respiratory Syncytial Virus Vaccines, Neutralizing antibody and Fusion protein. Peter L. Collins has included themes like Antigen and Nasal administration in his Antibody study. The Immunology study combines topics in areas such as Airway and Respiratory system.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASDThe Task Force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD)
Francesco Cosentino;Peter J Grant;Victor Aboyans;Clifford J Bailey.
European Heart Journal (2020)
The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins
Philip R. Johnson;Melanie K. Spriggs;Robert A. Olmsted;Peter L. Collins.
Proceedings of the National Academy of Sciences of the United States of America (1987)
Respiratory Syncytial Virus Infection of Human Airway Epithelial Cells Is Polarized, Specific to Ciliated Cells, and without Obvious Cytopathology
Liqun Zhang;Mark E. Peeples;Richard C. Boucher;Peter L. Collins.
Journal of Virology (2002)
Cardiovascular diseases in women: a statement from the policy conference of the European Society of Cardiology.
Marco Stramba-Badiale;Kim M. Fox;Silvia G. Priori;Peter Collins.
European Heart Journal (2006)
Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease
G.M.C. Rosano;P.M. Sarrel;P.A. Poole-Wilson;P. Collins.
The Lancet (1993)
Endothelium‐independent relaxation of rabbit coronary artery by 17β‐oestradiol in vitro
Canwen Jiang;Philip M. Sarrel;David C. Lindsay;Philip A. Poole-Wilson.
British Journal of Pharmacology (1991)
Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice
Himani Bisht;Anjeanette Roberts;Leatrice Vogel;Alexander Bukreyev.
Proceedings of the National Academy of Sciences of the United States of America (2004)
Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity
Robert A. Olmsted;Narayanasamy Elango;Gregory A. Prince;Brian R. Murphy.
Proceedings of the National Academy of Sciences of the United States of America (1986)
Nucleotide sequence of the G protein gene of human respiratory syncytial virus reveals an unusual type of viral membrane protein
G W Wertz;P L Collins;Y Huang;C Gruber.
Proceedings of the National Academy of Sciences of the United States of America (1985)
A Role for Immune Complexes in Enhanced Respiratory Syncytial Virus Disease
Fernando P. Polack;Michael N. Teng;Peter L.Collins;Gregory A. Prince.
Journal of Experimental Medicine (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: